EPIDEMIOLOGYPremature mortality due to cardiovascular disease in hypopituitarism
References (20)
- et al.
Studies of hyperlipidemia in the hGH-deficient state
Metabolism
(1972) - et al.
Growth hormone in the regulation of hyperlipidemia
Metabolism
(1982) - et al.
Effect of subacute administration of human growth hormone on various serum lipid and hormone levels of hypercholesteremic and normocholesterolemic subjects
Metabolism
(1974) - et al.
Beneficial effects of growth hormone treatment in GH-deficient adults
Lancet
(1989) Classification of deaths in Swedish statistics according to WHO, 8th revision of International Classification of Deaths
(May, 1987)Causes of death: annual publications for 1956-1987
(1989)- et al.
Myxofibrosarcoma: a malignant soft tissue tumour of fibroblastic-histiocytic origin
Acta Pathol Microbiol Immunol Scand
(1983) - et al.
Epidemiology of acromegaly in the Newcastle region
Clin Endocrinol
(1980) - et al.
Epidemiology and long-term survival in acromegaly: a study of 166 cases diagnosed between 1955 and 1984
Acta Med Scand
(1988)
There are more references available in the full text version of this article.
Cited by (1330)
Growth hormone treatment in aged patients with comorbidities: A systematic review
2024, Growth Hormone and IGF ResearchChronic heart failure: An appropriate clinical context to search for GH deficiency?
2024, European Journal of Internal MedicineRadiotherapy and Mortality in Pituitary Adenomas
2023, Archives of Medical ResearchMeta-analysis of mortality in adults with growth hormone deficiency: Does growth hormone replacement therapy really improve mortality rates?
2023, Best Practice and Research: Clinical Endocrinology and MetabolismDyslipidaemia and growth hormone deficiency – A comprehensive review
2023, Best Practice and Research: Clinical Endocrinology and MetabolismMechanisms of ageing: growth hormone, dietary restriction, and metformin
2023, The Lancet Diabetes and Endocrinology
Copyright © 1990 Published by Elsevier Ltd.